The Biodefense Market is expected to be around US$ 21.17 Billion by 2028 at a CAGR of 6.25% in the given forecast period.

Biodefense is a set medical or military events that are taken in response to restoring biosecurity of a country against infectious agents or biological toxins that can be used with an infect humans or intent to kill, animals, or the atmosphere and to instigate biological warfare. Biodefense can be defined as the action of preparing for, responding to and countering the acts of bioterrorism. A bioterrorism attack includes the viruses, deliberate release of bacteria, and other pathogens that can cause chronic illnesses to humans, agriculture, animals and the environment. Biodefense contains many medical measures that are undertaken to protect individuals against biological threats, such as administering vaccinations and medicinal drugs, along with conducting research and many public health procedures. Biodefense products are normally effective against anthrax, radiation/nuclear disasters, smallpox, botulism and other such catastrophes. Rising investment from private players, improved government focus and funding towards biodefense strategies, and increasing prevalence of several agents such as the Zika Virus, Ebola Virus, and Flu, are driving the market for biodefense. Moreover, there is an improvement, in terms of research and public health preparations, in order to defend against biological attacks. There is a growing alertness regarding synthetic biology, mostly for using biological organisms, to decrease the burden of diseases, especially for refining agricultural yields.

The global Biodefense market is segregated on the basis of Product as Anthrax, Smallpox, Botulism, Radiation/nuclear, and Others.

The global Biodefense market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biodefense market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

XOMA corporation, Altimmune Inc., Emergent Biosolutions Inc., Dynavax Technologies Corporation., SIGA Technologies., Elusys Therapeutics Inc., Ichor Medical Systems., Dynport Vaccine Company., ClevelandBiolabs., Bavarian Nordic., Ology Bioservices., Alnylam Pharmaceuticals Inc, and others are among the major players in the global Biodefense market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Biodefense Market has been segmented as below:

Biodefense Market, By Product

• Anthrax
• Smallpox
• Botulism
• Radiation/nuclear
• Others

Biodefense Market, By Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Biodefense Market, By Company

• XOMA corporation
• Altimmune Inc.
• Emergent Biosolutions Inc.
• Dynavax Technologies Corporation.
• SIGA Technologies.
• Elusys Therapeutics Inc.
• Ichor Medical Systems.
• Dynport Vaccine Company.
• ClevelandBiolabs.
• Bavarian Nordic.
• Ology Bioservices.
• Alnylam Pharmaceuticals Inc

The report covers:

• Global Biodefense market sizes from 2021 to 2028, along with CAGR for 2023-2028
• Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
• Global Biodefense market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Biodefense market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

Report Scope:

The global Biodefense market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biodefense market share. Major industry players with significant revenue share include XOMA corporation, Altimmune Inc., Emergent Biosolutions Inc., Dynavax Technologies Corporation., SIGA Technologies., Elusys Therapeutics Inc., Ichor Medical Systems., Dynport Vaccine Company., ClevelandBiolabs., Bavarian Nordic., Ology Bioservices., Alnylam Pharmaceuticals Inc, and others.

Reasons to Buy this Report:

• Gain detailed insights on the Biodefense industry trends
• Find complete analysis on the market status
• Identify the Biodefense market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Customization

Customized report as per the requirement can be offered with appropriate recommendations.

Below are our New Reports :-

DNA Polymerase Market

Artificial Grass market

Nitrogenous Fertilizes Market

Single-cell Analysis Market

Bio solids market